BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>
Trial results on new advanced prostate cancer drug will be out soon
September 12, 2010 by Jim Tucker
Posted in Treatment news | Tagged abiraterone acetate, advanced prostate cancer, Bloomberg Businessweek, cancer research, castration-resistant prostate cancer, catherise, catheter, catheterisation, metastatic advanced prostate cancer, prednisone, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment | Leave a Comment
Blog Stats
- 295,393 hits
Search
MY PROSTATE STORY
Prostate inquiry
Prostate websites
Prostablog RSS – click here
- Still here, still clear – 2020 June 24, 2020
- PSA treachery hits close to home May 18, 2019
- Coming up to a decade clear June 4, 2018
PROSTABLOG pages
Category cloud
AFTER EFFECTS Biochemical recurrence Biopsy Brachytherapy Checkups Diagnosis Dietary intervention Doctors' advice Erectile function FUND RAISING Govt prostate policy Hormone therapy Incontinence Natural remedies New prostate drugs New tests Prostate blogs PROSTATE CANCER Prostate claims Prostate prognosis PROSTATE RESEARCH PROSTATE RISKS PSA tests Public health system Radical prostatectomy Radiotherapy Rowing 4 Prostate Screening debate Treatment debate Treatment newsCOMMENTS
Leave a Reply